Arrowhead Pharmaceuticals... (ARWR)
NASDAQ: ARWR
· Real-Time Price · USD
20.50
1.72 (9.16%)
At close: Aug 15, 2025, 3:59 PM
20.90
1.93%
After-hours: Aug 15, 2025, 07:44 PM EDT
Arrowhead Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | -159.35M | -154.68M | -649.53M | -607.18M | -544.85M | -475M | -300.33M | -209.28M | -184.2M | -152.12M | -155.43M | -176.49M | -153.93M | -111.8M | -182.99M | -140.85M | -125.91M | -109.59M | -102.61M |
Depreciation & Amortization | 18.02M | 21.13M | 19.57M | 18.59M | 17.43M | 15.92M | 14.07M | 12.49M | 11.29M | 10.61M | 10.54M | 10.42M | 10.27M | 9.67M | 8.99M | 8.27M | 7.54M | 7.08M | 6.53M |
Stock-Based Compensation | 63.75M | 67.76M | 69.48M | 73.97M | 72.67M | 75.57M | 78.43M | 78.13M | 89.14M | 102.59M | 115.78M | 120.89M | 126.32M | 111.48M | 93.03M | 76.67M | 57.92M | 49.42M | 47.04M |
Other Working Capital | 24.58M | 71.9M | 21.03M | 30.63M | 44.55M | 18.25M | -66.87M | -87.55M | -127.71M | -147.3M | -89.66M | -97.08M | -73.33M | -76.82M | 211.37M | 224.49M | 204.63M | 234.24M | -46.87M |
Other Non-Cash Items | 71.34M | 56.26M | 40.68M | 26.68M | 29.29M | 21.42M | 16.73M | 18.33M | 11.61M | 10.68M | 11.16M | 7.34M | 7.89M | 4.55M | 288K | 266K | 14.56K | 299.09K | 45.86K |
Deferred Income Tax | n/a | n/a | n/a | n/a | -2.02M | -2.02M | -2.02M | -2.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 28.08M | 70.68M | 28.52M | 25.09M | 76.58M | 107.18M | -3.1M | -51.55M | -125.14M | -216.46M | -132.34M | -98.29M | -82.13M | -66.24M | 229.47M | 226.87M | 244.92M | 233.47M | -61.78M |
Operating Cash Flow | 21.84M | 61.15M | -491.28M | -462.85M | -350.89M | -256.92M | -196.21M | -153.89M | -197.3M | -244.7M | -150.3M | -136.13M | -91.58M | -52.34M | 148.8M | 171.22M | 184.49M | 180.67M | -110.78M |
Capital Expenditures | -39.47M | -51.55M | -80.33M | -141.47M | -181.09M | -213.24M | -206.48M | -176.74M | -145.54M | -108.47M | -85.91M | -52.78M | -28.27M | -22.66M | -25.07M | -23.57M | -17.25M | -15.46M | -11.9M |
Cash Acquisitions | n/a | n/a | n/a | n/a | -94.42M | -131.12M | -131.12M | -89.33M | 5.08M | -29.03M | -29.03M | -70.81M | -70.81M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.07B | -1.09B | -754.7M | -720.95M | -440.77M | -363.6M | -134.94M | -246.14M | -233.98M | -267.53M | -268.71M | -223.39M | -368.9M | -349.09M | -306.58M | -240.7M | -180.19M | -138.44M | -278.96M |
Sales Maturities Of Investments | 681.58M | 581.13M | 427.02M | 442.34M | 455.21M | 393.34M | 390.8M | 326.72M | 289.31M | 356.96M | 301.9M | 270.75M | 237.06M | 130.83M | 126.43M | 122.59M | 108.12M | 78.08M | 70.97M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 94.42M | 131.12M | 131.12M | 89.33M | 64.07M | 98.19M | 33.18M | 47.36M | -131.84M | -218.27M | -180.15M | -118.11M | -72.08M | -60.36M | -208M |
Investing Cash Flow | -424.84M | -559.28M | -408M | -420.07M | -166.64M | -183.49M | 49.38M | -96.16M | -90.22M | -19.04M | -52.73M | -5.42M | -160.11M | -240.93M | -205.22M | -141.68M | -89.33M | -75.82M | -219.9M |
Debt Repayment | 189.34M | 287.24M | 438.87M | 438.87M | 300M | 250M | 250M | 250M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -5M | -5M | n/a | -250.67M | -249.53M | -249.01M | 1.56M | 253.09M | 312.55M | 313.88M | 65.19M | 65.15M | 7.3M | 8.09M | 11.3M | 11.49M | 8.74M | 6.11M |
Financial Cash Flow | 459.43M | 552.49M | 890.89M | 870.52M | 481.58M | 432.33M | 2.08M | 252.38M | 253.09M | 312.55M | 313.88M | 65.19M | 65.15M | 7.3M | 8.09M | 11.3M | 11.49M | 10.87M | 9.57M |
Net Cash Flow | 60.39M | 58.01M | -4.33M | -8.21M | -35.94M | -7.25M | -144.03M | 2.89M | -34.1M | 48.55M | 110.66M | -76.43M | -186.54M | -285.97M | -48.33M | 40.85M | 106.66M | 115.73M | -321.11M |
Free Cash Flow | -17.62M | 9.6M | -571.61M | -604.32M | -531.98M | -470.16M | -402.7M | -330.63M | -342.84M | -353.17M | -236.21M | -188.91M | -119.85M | -75M | 123.72M | 147.66M | 167.24M | 165.21M | -122.69M |